No results for ‘’
Granules India Ltd
₹786.90
(0.61%)
Tue, 23 Jun 2026, 07:50 pm
Health Technology
Pharmaceuticals: Other
24.5KGranules India PE Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 18.64 | 15.31 | 23 | 8.65 | 6.19 | 8.85 | 5.45 | 6 | 7.01 | 19.26 | 20.57 | 18.52 | 18.91 | 12.32 | 10.92 | 13.82 | 18.45 | 13.83 | 25.71 | 23.55 |
| Price to book ratio | 1.82 | 1.28 | 1.41 | 0.43 | 0.93 | 0.84 | 0.66 | 0.69 | 1.46 | 4.03 | 3.93 | 3.51 | 2.01 | 1.90 | 1.98 | 3.46 | 2.94 | 2.48 | 3.23 | 3.18 |
| Price to sales ratio | 0.80 | 0.63 | 0.93 | 0.26 | 0.41 | 0.39 | 0.25 | 0.26 | 0.49 | 1.36 | 1.86 | 2.16 | 1.49 | 1.28 | 1.41 | 2.34 | 2.02 | 1.58 | 2.31 | 2.64 |
| Price to cash flow ratio | 0 | 26.59 | 0 | 0 | 4.19 | 5.22 | 10.94 | 2.55 | 5.96 | 14.54 | 21.28 | 18.95 | 0 | 12.05 | 8.09 | 18 | 23.80 | 10.35 | 30.69 | 15.41 |
| Enterprise value | 180Cr | 215Cr | 272Cr | 245Cr | 321Cr | 310Cr | 347Cr | 415Cr | 914Cr | 2167Cr | 3041Cr | 3654Cr | 3370Cr | 3815Cr | 4271Cr | 8169Cr | 8312Cr | 7968Cr | 11349Cr | 12671Cr |
| Enterprise value to EBITDA ratio | 9.23 | 8.51 | 9.24 | 0 | 5.17 | 5.65 | 4.57 | 4.78 | 5.72 | 10.30 | 10.96 | 11.89 | 12.02 | 9.90 | 7.52 | 9.38 | 11.18 | 8.54 | 12.77 | 13.17 |
| Debt to equity ratio | 1.29 | 1.36 | 0.80 | 1.05 | 0.72 | 0.62 | 0.88 | 0.99 | 1.21 | 1.12 | 0.97 | 0.73 | 0.75 | 0.65 | 0.48 | 0.39 | 0.43 | 0.40 | 0.41 | 0.39 |
| Return on equity % | 11.46 | 9.68 | 6.15 | 5.06 | 16.10 | 9.90 | 12.89 | 12.54 | 23.89 | 23.12 | 22.52 | 21.02 | 12.01 | 16.69 | 19.89 | 27.36 | 17.34 | 19.06 | 13.38 | 14.45 |
Granules India Ltd Price to Earnings Ratio
The Granules India Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Granules India Ltd's valuation, profitability, and overall financial performance. Tracking the Granules India Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Granules India Ltd (NSE: GRANULES, BSE: 532482) is currently trading at ₹786.90, with a market capitalization of ₹19386.39Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Granules India Ltd Price to Earnings Ratio is essential for fundamental analysis.
Granules India Ltd Price to Earnings Ratio Current Value
The current Granules India Ltd Price to Earnings Ratio stands at 23.55.
The Granules India Ltd Price to Earnings Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Granules India Ltd Price to Earnings Ratio Historical Trend
The Granules India Ltd Price to Earnings Ratio has shown the following historical trend:
- 2024: 23.55
- 2023: 25.71
- 2022: 13.83
- 2021: 18.45
- 2020: 13.82
The decline in Granules India Ltd Price to Earnings Ratio indicates improving financial efficiency or better earnings growth.
What Granules India Ltd Price to Earnings Ratio Indicates for Investors
The Granules India Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Granules India Ltd Price to Earnings Ratio Analysis Summary
The Granules India Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Granules India Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Granules India Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.